Author/Authors :
Nazem, Khalilallah Associate Professor - Department of Orthopedics, Isfahan University of Medical Sciences , Safdarian, Ahmad Resident - Department of Orthopedics - School of Medicine and Student Research Committee Isfahan University of Medical Sciences , Fesharaki, Mehrafarin Department of Stem Cell - Cell Science Research Center - Royan Institute (Isfahan Campus) - ACECR, Isfahan , Moulavi, Fariba Department of Stem Cell - Cell Science Research Center - Royan Institute (Isfahan Campus) - ACECR, Isfahan , Motififard, Mahdi Assistant Professor - Department of Orthopedics, Isfahan University of Medical Sciences , Zarezadeh, Abolghasem Assistant Professor - Department of Orthopedics, Isfahan University of Medical Sciences , Shakibaei, Mahdi Assistant Professor - Department of Anatomy - Islamic Azad University of Medical Sciences , Esfandiari, Ebrahim Associate Professor, Department of Anatomy, Isfahan University of Medical Sciences , Nasr-Esfahani, Mohammad Hossin Professor - Department of Anatomy, Isfahan University of Medical Sciences
Abstract :
BACKGROUND: Although a variety of strategies have been employed for managing articular cartilage defects in the
knee, overall outcomes have not been satisfactory. An alternative option may be autologous chondrocyte transplantation
(ACT). However, as this method is still under investigation, here we assessed the efficacy of ACT for human knee defect
cartilage repair.
METHODS: In a randomized clinical trial study, eleven patients (mean age 31.09 years) were enrolled in the study with
full thickness cartilage defects in the knee. Arthroscopically, healthy cartilage was obtained, chondrocytes expanded for
2-3 weeks and ACT performed. Clinical status was evaluated before ACT, 6 and 12 months after ACT using the Brittberg-
Peterson functional assessment and modified Cincinnati rating score. Magnetic resonance imaging (MRI) findings
were evaluated based on the scoring systems used by Sally Roberts and by Henderson.
RESULTS: Modified Cincinnati rating indicated significant improvement of clinical score before ACT compared to 6 (p
= 0.000) and 12 (p = 0.000) months after ACT (from 2.73 before ACT to 7.27, 8.36 and 9.5 at 6, 12, and 48 months
after ACT, respectively). Brittberg-Peterson functional assessment indicated a decline from 79.27 to 25.82 and 19.27 at
6 and 12 months post ACT. Further, statistical test demonstrated significant differences 6, 12 and 48 months post ACT
(p = 0.007). Evaluation of MRI revealed a score of 6.5 for Henderson criteria and a score of 2.5 for Robert criteria.
CONCLUSIONS: Our study demonstrated that ACT of the knee provides an excellent treatment for full thickness cartilage
defects with outstanding clinical and radiological outcomes
Keywords :
Articular Cartilage , Full Thickness Cartilage Defect , Autologus Chondrocyte Transplantation , Knee
